Docusign (NASDAQ:DOCU) Director Sells 1,096 Shares

September 17, 2026 by InsiderTrades.com

Key Points

Director Mary Agnes Wilderotter sold 1,096 DocuSign shares for approximately $77,378 at an average price of $70.60 under a pre-arranged Rule 10b5-1 plan, reducing her holdings by 25.52%.
DocuSign’s latest results exceeded expectations, with quarterly revenue of $875.75 million and EPS of $1.16; revenue increased 9.4% year over year.
DOCU has a consensus “Hold” rating and a $67.33 average price target, while the stock trades at roughly 43 times earnings; institutional investors own 77.64% of the shares.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Mary Agnes Wilderotter sold 1,096 shares of the business's stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $70.60, for a total value of $77,377.60. Following the completion of the transaction, the director directly owned 3,199 shares of the company's stock, valued at approximately $225,849.40. This trade represents a 25.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Down 2.0%

MarketBeat Week in Review – 09/07 - 09/11

DOCU opened at $70.40 on Thursday. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $86.65. The company has a 50-day simple moving average of $59.16 and a 200 day simple moving average of $51.23. The stock has a market capitalization of $13.16 billion, a price-to-earnings ratio of 42.93, a P/E/G ratio of 2.70 and a beta of 0.90.

Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The firm had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. During the same period last year, the firm earned $0.30 EPS. The business's quarterly revenue was up 9.4% compared to the same quarter last year. Sell-side analysts anticipate that Docusign Inc. will post 2.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Docusign

Docusign’s AI Push Is Giving Investors a Reason to Rethink the Stock

Several hedge funds and other institutional investors have recently made changes to their positions in DOCU. BlackRock Inc. bought a new position in Docusign in the 2nd quarter valued at approximately $927,059,000. Capital World Investors grew its stake in shares of Docusign by 38.1% during the fourth quarter. Capital World Investors now owns 5,815,804 shares of the company's stock worth $397,801,000 after buying an additional 1,603,900 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Docusign by 76.1% during the first quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company's stock worth $250,568,000 after buying an additional 2,283,996 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Docusign by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company's stock worth $278,665,000 after buying an additional 18,873 shares in the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of Docusign by 4.0% during the first quarter. Renaissance Technologies LLC now owns 3,170,061 shares of the company's stock worth $150,293,000 after buying an additional 123,100 shares in the last quarter. 77.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DOCU. Wells Fargo & Company lifted their price objective on shares of Docusign from $55.00 to $60.00 and gave the company an "equal weight" rating in a research note on Friday, September 4th. Citizens Jmp restated a "market outperform" rating and set a $86.00 target price on shares of Docusign in a research note on Friday, September 4th. Needham & Company LLC reaffirmed a "hold" rating on shares of Docusign in a report on Friday, September 4th. Citigroup lifted their price target on Docusign from $54.00 to $72.00 and gave the company a "neutral" rating in a research note on Friday, September 4th. Finally, Royal Bank Of Canada boosted their price target on Docusign from $55.00 to $70.00 and gave the stock a "sector perform" rating in a report on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $67.33.

Docusign: Another Beat, Another Selloff—Why the Analysts Are Wrong

View Our Latest Stock Analysis on DOCU

Key Docusign News

Here are the key news stories impacting Docusign this week:

Positive Sentiment: DocuSign was named a Leader in the 2026 IDC MarketScape for Worldwide Integrated Signing Workflow Software. The recognition supports the company’s competitive standing as it expands Intelligent Agreement Management and AI-powered workflows. DocuSign Named a Leader in the IDC MarketScape
Positive Sentiment: Investors continue to focus on DocuSign’s AI initiatives, including integrations with AI agents and its Model Context Protocol Server. The company also raised full-year revenue guidance and completed a $2.38 billion share-repurchase program covering more than 20% of its shares, which could support earnings per share and shareholder returns. DocuSign’s AI Push and Buyback
Positive Sentiment: The consensus analyst price target rose 17.43% to $71.83, reflecting improved expectations for DOCU’s outlook. Recent quarterly results also exceeded forecasts, with $875.75 million in revenue, $1.16 in adjusted EPS and 9.4% year-over-year revenue growth. DocuSign Consensus Price Target Raised
Neutral Sentiment: Director Mary Agnes Wilderotter sold 1,096 shares for approximately $77,378, reducing her position by 25.52%. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, making it less informative about management’s current outlook. SEC Insider Trading Filing
Neutral Sentiment: Director Anna Marrs separately sold 548 shares for about $36,716 under a 10b5-1 plan. The sale represented only 3.89% of her holdings and is unlikely, by itself, to indicate a change in business expectations. SEC Insider Trading Filing
Negative Sentiment: Despite the improved outlook, DOCU trades at a relatively elevated valuation—roughly 43 times earnings—and the average analyst rating remains “Hold,” with several firms maintaining neutral or underperform ratings. This may limit upside after the recent rally.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company's products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.